New study results presented at the annual meeting suggest that immunoglobulin G4 (IgG) antiphospholipid antibody positivity may be an important but overlooked risk factor for myocardial infarction (MI).
Patients with knee osteoarthritis (OA) who walk with moderate to vigorous intensity may lower their risk of total knee arthroplasty (TKA), according to new research presented at the annual meeting.
The American College of Rheumatology (ACR) and European League Against Rheumatism have presented a draft of “Classification Criteria for IgG4-related Disease,” the first classification criteria developed for the recently recognized disease. The criteria were unveiled during a session at the annual meeting, and they are under review by both associations for endorsement.
According to research presented at the annual meeting, women who experienced physical or emotional abuse in childhood have a significantly higher risk of developing systemic lupus erythematosus (SLE) in adulthood.
During the annual meeting, a standing-room-only audience attended a product theater on Cosentyx® (secukinumab), manufactured by Novartis, which is used to treat several forms of spondyloarthritis.
At a dinner symposium hosted by Novartis at the annual meeting, a panel of experts explained the irreconcilable differences between psoriatic arthritis (PsA) and rheumatoid arthritis (RA).